ストックスクリーナーアプリを入手
169.12
0.91%
-1.56
アフターアワーズ：
169.20
0.08
+0.05%
Iqvia Holdings Inc (IQV) 最新ニュース
Is There Now An Opportunity In IQVIA Holdings Inc. (NYSE:IQV)? - Moomoo
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BeOne Medicines (ONC) and Nektar Therapeutics (NKTR) - The Globe and Mail
Will IQVIA's (IQV) AI‑Driven Biosimilar Partnership with Kexing Reshape Its Long‑Term Narrative? - Yahoo Finance
IQVIA Holdings earnings preview: What to expect - MSN
BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $245 - Moomoo
IQVIA Holdings stock (US46266C1053): Expands AI-powered biosimilars deal with Kexing Biopharm - AD HOC NEWS
IQVIA Holdings, Inc. Common Stock (NY: IQV - FinancialContent
IQVIA expands collaboration with Kexing Biopharm on biosimilars - Investing.com UK
Why (IQV) Price Action Is Critical for Tactical Trading - Stock Traders Daily
IQVIA expands collaboration with Kexing Biopharm on biosimilars By Investing.com - Investing.com Nigeria
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
AI-powered trials to speed global biosimilar drugs in IQVIA-Kexing pact - Stock Titan
IQVIA Holdings stock (US46266C1053): Global leader in healthcare data analytics - AD HOC NEWS
Assessing IQVIA Holdings (IQV) Valuation After Expanded AI Clinical Trial Collaboration With Kexing Biopharm - Sahm
IQVIA Q1 2026 slides: earnings beat drives guidance raise By Investing.com - Investing.com Canada
IQVIA Q1 2026 slides: earnings beat drives guidance raise - Investing.com
Earnings call transcript: IQVIA surpasses Q1 2026 forecasts, stock surges - Investing.com
Earnings call transcript: IQVIA surpasses Q1 2026 forecasts, stock surges By Investing.com - Investing.com Australia
IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions - Barchart.com
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA (NYSE: IQV) director granted 171 deferred shares at $178.64 - Stock Titan
IQVIA (NYSE: IQV) director Colleen Goggins receives 214 Deferred Shares grant - Stock Titan
IQVIA (NYSE: IQV) director Jim Fasano receives 228 deferred share award - Stock Titan
IQVIA (NYSE: IQV) director awarded 185 deferred shares with 1:1 common conversion - Stock Titan
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout
IQVIA Holdings Inc. (IQV): Larry Robbins Is Bullish on This Stock - Insider Monkey
Why IQVIA Holdings (IQV) Is Up 12.8% After Q1 Beat and Bigger Buyback Plan – And What's Next - Sahm
Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China - GlobeNewswire Inc.
IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth Potential With A 27.92% Upside - DirectorsTalk Interviews
IQVIA Q1 Earnings Call Highlights - sharewise.com
Here's why you should retain IQV stock in your portfolio now - MSN
IQVIA Holdings stock (US46266C1053): Data?driven healthcare analytics in focus for US investors - AD HOC NEWS
IQVIA board authorizes additional $2B in share repurchases - MSN
IQVIA Expands Share Repurchase Authorization by $2 Billion - The Globe and Mail
BMO Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210 - Moomoo
IQVIA Holdings Inc. (NYSE:IQV) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
IQVIA Holdings | 8-K: Current report - Moomoo
Earnings Update: IQVIA Holdings Inc. (NYSE:IQV) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
IQVIA Increases Share Repurchase Authorization by $2 Billion, Bringing Total to $3.2 Billion 1 - Minichart
Artificial Intelligence in Epidemiology Market Is Going - openPR.com
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization - The National Law Review
IQVIA Board Approves $2B Increase to Share Repurchase Authorization, $3.2B Remaining - TradingView
IQVIA board authorizes additional $2 billion stock buyback - Investing.com
IQVIA board authorizes additional $2 billion stock buyback By Investing.com - Investing.com Australia
IQVIA (NYSE: IQV) boosts buyback plan, $3.2B now authorized - Stock Titan
5.36%
大文字化:
|
ボリューム (24 時間):